CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--PBM Capital Group, a healthcare-focused private investment firm, announces an investment in Xalud Therapeutics (www.xaludthera.com). This round of financing will help support the company’s gene therapy platform targeting multiple neuro-inflammatory diseases. PBM will have two representatives on Xalud’s Board of Directors and will also provide operational support to the Company.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
